Frontiers in Medical Technology (Oct 2022)

Integration of artificial intelligence and precision oncology in Latin America

  • Liliana Sussman,
  • Liliana Sussman,
  • Juan Esteban Garcia-Robledo,
  • Juan Esteban Garcia-Robledo,
  • Camila Ordóñez-Reyes,
  • Camila Ordóñez-Reyes,
  • Yency Forero,
  • Yency Forero,
  • Andrés F. Mosquera,
  • Andrés F. Mosquera,
  • Alejandro Ruíz-Patiño,
  • Alejandro Ruíz-Patiño,
  • Diego F. Chamorro,
  • Diego F. Chamorro,
  • Andrés F. Cardona,
  • Andrés F. Cardona,
  • Andrés F. Cardona

DOI
https://doi.org/10.3389/fmedt.2022.1007822
Journal volume & issue
Vol. 4

Abstract

Read online

Next-generation medicine encompasses different concepts related to healthcare models and technological developments. In Latin America and the Caribbean, healthcare systems are quite different between countries, and cancer control is known to be insufficient and inefficient considering socioeconomically discrepancies. Despite advancements in knowledge about the biology of different oncological diseases, the disease remains a challenge in terms of diagnosis, treatment, and prognosis for clinicians and researchers. With the development of molecular biology, better diagnosis methods, and therapeutic tools in the last years, artificial intelligence (AI) has become important, because it could improve different clinical scenarios: predicting clinically relevant parameters, cancer diagnosis, cancer research, and accelerating the growth of personalized medicine. The incorporation of AI represents an important challenge in terms of diagnosis, treatment, and prognosis for clinicians and researchers in cancer care. Therefore, some studies about AI in Latin America and the Caribbean are being conducted with the aim to improve the performance of AI in those countries. This review introduces AI in cancer care in Latin America and the Caribbean, and the advantages and promising results that it has shown in this socio-demographic context.

Keywords